Lv2
128 积分 2021-09-10 加入
Distinct brain regions mediate regulation of food intake in response to GIPR agonism or antagonism
1个月前
已完结
Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation
2个月前
已完结
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
2个月前
已完结
Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial
2个月前
已完结
Comparative Pharmacology of the 3 Marketed Dual Orexin Antagonists—Daridorexant, Lemborexant, and Suvorexant: Part 1: Pharmacokinetic Profiles
5个月前
已完结
Comparative Pharmacology of the 3 Marketed Dual Orexin Antagonists—Daridorexant, Lemborexant, and Suvorexant—Part 2. Principal Drug Metabolizing Enzyme, Drug-Drug Interactions, and Effects of Liver and Renal Impairment on Metabolism
5个月前
已完结
Abstract 17217: ActRIIA-Fc Rebalances Activin/GDF and BMP9 Signaling to Attenuate Experimental Pulmonary Hypertension
5个月前
已关闭
Dexrazoxane Alleviated Doxorubicin-Induced Nephropathy in Rats
8个月前
已完结
Differential disruption on glucose and insulin metabolism in two rat models of diet-induced obesity, based on carbohydrates or lipids
9个月前
已完结
皖公网安备34019202002308
